Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hanawa

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Japanese Circulation Journal|August 26, 1998
Hypertrophic cardiomyopathy with type I CD36 deficiencyK Watanabe, K Toba, Y Ogawa, et al.
Journal of Cardiovascular Pharmacology|February 24, 2001
Acute effects of endothelin-1 and TAK-044 (ET(A) and ET(B) receptor antagonist) in rats with dilated cardiomyopathyK Watanabe, Y Ohta, T Kouda, et al.
Annals of Nuclear Medicine|December 5, 1998
Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiencyK Watanabe, Y Ohta, K Toba, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Japanese Circulation Journal|August 26, 1998
Hypertrophic cardiomyopathy with type I CD36 deficiencyK Watanabe, K Toba, Y Ogawa, et al.
Journal of Cardiovascular Pharmacology|February 24, 2001
Acute effects of endothelin-1 and TAK-044 (ET(A) and ET(B) receptor antagonist) in rats with dilated cardiomyopathyK Watanabe, Y Ohta, T Kouda, et al.
Annals of Nuclear Medicine|December 5, 1998
Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiencyK Watanabe, Y Ohta, K Toba, et al.
Pageof 8